Bioinformatics analyzes large-scale biological data through omics approaches to uncover disease mechanisms and identify therapeutic targets. Building on these data-driven methods, the field now predicts drug toxicity, sensitivity, and interactions, enabling early assessment of drug safety and efficacy. This early evaluation substantially reduces the cost and time of drug development.
Artificial intelligence has further broadened this scope, notably through molecule generation that automatically designs novel drug candidates. By complementing experimental biology and strengthening data-driven decisions, such approaches improve the efficiency of drug discovery pipelines. Bioinformatics has thus become a core technology advancing pharmaceutical innovation and the precision of future medicine.
Medical informatics integrates statistics, computer science, and medicine to systematically collect and analyze medical data, improving the efficiency of diagnosis and treatment. By analyzing medical big data, it identifies disease patterns and risk factors while supporting public health policy and preventive strategies. These quantitative insights underpin clinical decision support systems that, combined with artificial intelligence, help professionals make accurate and consistent judgments.
Recently, integrating machine learning with patients' genetic and clinical information has advanced early diagnosis and prognosis prediction. These methods enable earlier intervention and personalized treatment plans. Medical informatics thus accelerates the shift from reactive to predictive and preventive care, serving as a cornerstone of precision medicine and digital healthcare innovation.
Toxicity Prediction
AI-based models support broad toxicity assessment for diverse chemical and bio-based materials, including green biomaterials and related materials. By integrating chemical, biological, exposure, and contextual data, they help identify potential safety concerns, interpret relevant endpoints and risk factors, and estimate possible biological impacts. This supports non-animal evaluation, material prioritization, risk management, and regulatory decision-making.
Drug sensitivity
AI-based models analyze expected biological responses to functional materials and drug combinations by reflecting patient-, tissue-, and disease-related contexts. By integrating omics networks, pretrained representations, and diverse biomedical data, they help predict material combinations, combination responses, response variability, and condition-specific safety. This supports precision preclinical evaluation and tailored application strategies.
Drug – Drug interaction
AI-enabled safety assessment supports the evaluation of drug-combination risks by integrating literature-derived evidence, biological network analysis, and patient-related context. It helps examine potential interaction signals, combination responses, multi-component and multi-target relationships, and patient-specific safety considerations. These insights can provide supporting evidence for safer product development, risk review, and decision-making.
Molecule generation
AI-based approaches support the discovery of candidate materials aligned with desired functionality and safety goals. By integrating molecular, chemical, biological, and contextual information, they help explore possible alternatives, combinations, and improvement strategies while maintaining intended functions. The platform can further provide supporting evidence for material selection, safety review, product development, and follow-up validation.
Omics analysis
AI-based omics models analyze expected biological responses to functional materials and drug combinations by reflecting patient-, tissue-, and disease-related contexts. By integrating omics networks, pretrained representations, and diverse biomedical data, they help predict material combinations, combination responses, response variability, and condition-specific safety. This supports precision preclinical evaluation and tailored application strategies.
Prognosis prediction
Prognosis prediction involves estimating the likely course and outcome of a disease based on patient characteristics and clinical data. By analyzing factors such as age, disease stage, and treatment response, healthcare providers can anticipate how a condition may progress over time. This helps guide treatment planning and supports more personalized approaches to long-term patient care.
Statistical analysis
Statistical analysis of clinical data examines patient records to find meaningful patterns, correlations, and differences across treatment groups. It applies statistical methods to evaluate treatment efficacy, safety outcomes, and clinical significance. It assesses relationships between clinical variables and patient outcomes, yielding trustworthy results that support evidence-based decisions in care.
Clinical decision support
Clinical decision support refers to tools that assist healthcare providers in making informed decisions about diagnosis, treatment, and patient care. By integrating patient data with clinical knowledge, these systems provide timely recommendations and alerts at the point of care. This helps reduce errors, improve diagnostic accuracy, and ensure treatments align with best practices, supporting safer care.
Epidemiological study
An epidemiological study examines the distribution, patterns, and determinants of health conditions within populations. By analyzing data across groups, researchers can identify risk factors, track disease trends, and understand how environmental or behavioral factors contribute to illness. These studies play a vital role in public health, informing prevention strategies and guiding policy decisions.
Early diagnosis
Early diagnosis refers to identifying a disease or health condition in its initial stages, often before symptoms become severe. Detecting conditions early allows providers to begin treatment sooner, improving patient outcomes and reducing complications. This is especially critical for diseases like cancer, where timely intervention can slow progression and increase the chance of recovery.
